Target Name: LOC105370616
NCBI ID: G105370616
Review Report on LOC105370616 Target / Biomarker Content of Review Report on LOC105370616 Target / Biomarker
LOC105370616
Other Name(s): uncharacterized LOC105370616 | LOC105370616 variant X1 | Uncharacterized LOC105370616, transcript variant X1

LOC105370616: A Promising Drug Target for Various Diseases

LOC105370616 is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the superfamily of transmembrane protein (SMP) family, which includes proteins that are involved in various cellular processes, including signaling, structure, and regulation of ion channels and transport.

Recent studies have identified LOC105370616 as a potential drug target for various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. Its unique expression pattern and structural features make it an attractive target for small molecule inhibitors.

One of the key challenges in studying LOC105370616 is its expression pattern. While it is widely expressed in many tissues, its levels are highly variable between different cell types and experimental conditions. This makes it difficult to study its function and potential as a drug target.

However, researchers have been able to identify some of the key factors that regulate LOC105370616 expression. For example, they have found that LOC105370616 is regulated by the post-transcriptional modification (RNA modification) pathway, which involves the addition of various post-transcriptional modifications to mRNA. These modifications, such as phosphorylation and ubiquitination, can alter the stability and localization of the protein.

Another factor that has been found to regulate LOC105370616 expression is its interaction with other proteins. Researchers have identified a number of potential LOC105370616 interactors, including transcription factors, signaling molecules, and other proteins involved in cellular processes. These interactions may play a role in the regulation of LOC105370616 expression and its function as a drug target.

In addition to its expression and interaction with other proteins, LOC105370616 has also been identified as a potential biomarker for a number of diseases. For example, studies have shown that LOC105370616 is overexpressed in various cancer tissues and is associated with poor prognosis. Similarly, LOC105370616 has also been shown to be overexpressed in neurodegenerative diseases, including Alzheimer's disease, and is associated with increased risk of cognitive impairment.

Despite these promising findings, much more research is needed to fully understand the function and potential of LOC105370616 as a drug target. This will involve a combination of techniques, including biochemical, cellular, and animal studies, to determine the underlying mechanisms of its regulation and its potential as a therapeutic intervention.

In conclusion, LOC105370616 is a protein that has great potential as a drug target due to its unique expression pattern and interaction with other proteins. Further research is needed to fully understand its function and potential as a therapeutic intervention for various diseases.

Protein Name: Uncharacterized LOC105370616

The "LOC105370616 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105370616 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105370617 | LOC105370619 | LOC105370627 | LOC105370645 | LOC105370660 | LOC105370706 | LOC105370721 | LOC105370740 | LOC105370819 | LOC105370826 | LOC105370832 | LOC105370834 | LOC105370841 | LOC105370842 | LOC105370843 | LOC105370844 | LOC105370845 | LOC105370846 | LOC105370852 | LOC105370878 | LOC105370891 | LOC105370892 | LOC105370905 | LOC105370906 | LOC105370913 | LOC105370914 | LOC105370941 | LOC105370955 | LOC105370965 | LOC105370978 | LOC105370980 | LOC105370982 | LOC105370988 | LOC105370991 | LOC105370995 | LOC105371002 | LOC105371006 | LOC105371060 | LOC105371061 | LOC105371068 | LOC105371069 | LOC105371072 | LOC105371081 | LOC105371082 | LOC105371097 | LOC105371114 | LOC105371116 | LOC105371160 | LOC105371164 | LOC105371230 | LOC105371268 | LOC105371269 | LOC105371274 | LOC105371275 | LOC105371276 | LOC105371278 | LOC105371279 | LOC105371308 | LOC105371347 | LOC105371356 | LOC105371371 | LOC105371388 | LOC105371401 | LOC105371413 | LOC105371427 | LOC105371441 | LOC105371442 | LOC105371444 | LOC105371446 | LOC105371449 | LOC105371461 | LOC105371465 | LOC105371468 | LOC105371470 | LOC105371475 | LOC105371483 | LOC105371487 | LOC105371497 | LOC105371513 | LOC105371522 | LOC105371529 | LOC105371536 | LOC105371611 | LOC105371614 | LOC105371642 | LOC105371649 | LOC105371655 | LOC105371661 | LOC105371664 | LOC105371665 | LOC105371671 | LOC105371675 | LOC105371692 | LOC105371701 | LOC105371702 | LOC105371719 | LOC105371720 | LOC105371730 | LOC105371744 | LOC105371749